| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-13 11:48:50 UTC |
|---|
| Update Date | 2021-09-14 15:19:57 UTC |
|---|
| HMDB ID | HMDB0041936 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Morphine-3-glucuronide |
|---|
| Description | Morphine-3-glucuronide belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. In humans, morphine-3-glucuronide is involved in the morphine action pathway. Morphine-3-glucuronide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Morphine-3-glucuronide. |
|---|
| Structure | [H][C@@]12CC3=C4C(O[C@H]5[C@@H](O)C=C[C@@H]1[C@@]45CCN2C)=C(O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C=C3 InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-4-12(25)20(23)32-18-13(5-2-9(14(18)23)8-11(10)24)31-22-17(28)15(26)16(27)19(33-22)21(29)30/h2-5,10-12,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,12-,15-,16-,17+,19-,20-,22+,23-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Morphine 3-glucuronide(minor) | HMDB | | Morphine-3beta-D-glucuronide | HMDB |
|
|---|
| Chemical Formula | C23H27NO9 |
|---|
| Average Molecular Weight | 461.4618 |
|---|
| Monoisotopic Molecular Weight | 461.168581467 |
|---|
| IUPAC Name | (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(1S,5R,13R,14S,17R)-14-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10,15-tetraen-10-yl]oxy}oxane-2-carboxylic acid |
|---|
| Traditional Name | morphine-3-glucuronide |
|---|
| CAS Registry Number | 20290-09-9 |
|---|
| SMILES | [H][C@@]12CC3=C4C(O[C@H]5[C@@H](O)C=C[C@@H]1[C@@]45CCN2C)=C(O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C=C3 |
|---|
| InChI Identifier | InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-4-12(25)20(23)32-18-13(5-2-9(14(18)23)8-11(10)24)31-22-17(28)15(26)16(27)19(33-22)21(29)30/h2-5,10-12,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,12-,15-,16-,17+,19-,20-,22+,23-/m0/s1 |
|---|
| InChI Key | WAEXKFONHRHFBZ-ZXDZBKESSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as morphinans. These are polycyclic compounds with a four-ring skeleton with three condensed six-member rings forming a partially hydrogenated phenanthrene moiety, one of which is aromatic while the two others are alicyclic. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Morphinans |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Morphinans |
|---|
| Alternative Parents | |
|---|
| Substituents | - Morphinan
- Fatty acyl glycoside
- Fatty acyl glycoside of mono- or disaccharide
- Phenolic glycoside
- 1-o-glucuronide
- O-glucuronide
- Phenanthrene
- Glucuronic acid or derivatives
- Alkyl glycoside
- Glycosyl compound
- O-glycosyl compound
- Tetralin
- Coumaran
- Alkyl aryl ether
- Beta-hydroxy acid
- Aralkylamine
- Pyran
- Piperidine
- Oxane
- Benzenoid
- Fatty acyl
- Hydroxy acid
- Monosaccharide
- Tertiary amine
- Secondary alcohol
- Amino acid or derivatives
- Amino acid
- Tertiary aliphatic amine
- Organoheterocyclic compound
- Oxacycle
- Monocarboxylic acid or derivatives
- Azacycle
- Acetal
- Polyol
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Organooxygen compound
- Organic oxygen compound
- Organopnictogen compound
- Carbonyl group
- Alcohol
- Organic oxide
- Amine
- Organic nitrogen compound
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.02 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.2839 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 6.72 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 319.0 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 774.2 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 215.0 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 95.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 189.2 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 63.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 296.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 319.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 901.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 661.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 124.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 829.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 208.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 228.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 618.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 569.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 229.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Morphine-3-glucuronide,1TMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3715.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3707.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3728.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3715.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3661.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3641.9 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #10 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3648.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3693.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3704.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3695.1 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3652.7 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #6 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3695.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #7 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3696.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #8 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3653.8 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TMS,isomer #9 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3695.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3666.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #10 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3638.6 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3657.9 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3660.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3686.7 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3688.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #6 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3684.6 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #7 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3642.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #8 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3649.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TMS,isomer #9 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3668.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,4TMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3665.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,4TMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3672.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,4TMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3663.6 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,4TMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3675.7 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,4TMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3645.1 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,5TMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]6O[Si](C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C)C=C[C@H]3[C@H]1C5 | 3688.9 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TBDMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 3949.9 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TBDMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3935.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TBDMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3956.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TBDMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3944.1 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,1TBDMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 3906.4 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4097.9 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #10 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4105.4 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4140.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4161.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4157.4 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4104.6 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #6 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4122.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #7 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4123.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #8 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4111.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,2TBDMS,isomer #9 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4124.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #1 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4318.3 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #10 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4288.1 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #2 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4317.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #3 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4326.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #4 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4324.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #5 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4330.0 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #6 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O[Si](C)(C)C(C)(C)C)C=C[C@H]3[C@H]1C5 | 4329.2 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #7 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4288.1 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #8 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4300.5 | Semi standard non polar | 33892256 | | Morphine-3-glucuronide,3TBDMS,isomer #9 | CN1CC[C@]23C4=C5C=CC(O[C@@H]6O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]6O[Si](C)(C)C(C)(C)C)=C4O[C@H]2[C@@H](O)C=C[C@H]3[C@H]1C5 | 4290.9 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-052f-9015500000-6efd8a07efbced2ab8d5 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (3 TMS) - 70eV, Positive | splash10-03di-5312039000-4e3af59a311a1a8d4ff3 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (TBDMS_2_9) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (TBDMS_3_6) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (TBDMS_3_9) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS (TBDMS_3_10) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Morphine-3-glucuronide GC-MS ("Morphine-3-glucuronide,2TBDMS,#9" TMS) - 70eV, Positive | Not Available | 2021-10-14 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 10V, Positive-QTOF | splash10-01pc-0090700000-e7fd49d19d854ee34daf | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 20V, Positive-QTOF | splash10-000i-0090000000-6e5563d713276370c128 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 40V, Positive-QTOF | splash10-01bi-2190000000-6b6a368a1d84af573a8c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 10V, Negative-QTOF | splash10-03e9-2341900000-9ae8b4daaa0b2d5ff3fa | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 20V, Negative-QTOF | splash10-001i-1290200000-3a05bfbed3f84a1ef6aa | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 40V, Negative-QTOF | splash10-001i-3190000000-22d2ab5a61d00c8fce61 | 2016-08-04 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 10V, Positive-QTOF | splash10-03di-0020900000-1b82a39d0f82654a2fb1 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 20V, Positive-QTOF | splash10-03di-0102900000-106eb410bb82e75a5c4a | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 40V, Positive-QTOF | splash10-03di-1428900000-d63c346ba4273670de27 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 10V, Negative-QTOF | splash10-03di-0000900000-c23f6d27b4578a388ccf | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 20V, Negative-QTOF | splash10-03e9-5182900000-608ad169cb44cb21ee66 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Morphine-3-glucuronide 40V, Negative-QTOF | splash10-0a4i-9044200000-e8b066d4574999b9f9e4 | 2021-09-23 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
|
|---|